Yüklüyor......
Update on pharmacotherapies for cholestatic liver disease
Cholestatic liver diseases are conditions with impaired bile formation and/or flow due to genetic, immunologic, environmental, or other causes. Unless successfully treated, this can lead to chronic liver injury and end‐stage liver disease. Primary biliary cholangitis (PBC) and primary sclerosing cho...
Kaydedildi:
| Yayımlandı: | Hepatol Commun |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5747033/ https://ncbi.nlm.nih.gov/pubmed/29404429 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep4.1013 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|